CG Oncology Inc. (CGON) vs Sotera Health Company (SHC)
A side-by-side comparison of CG Oncology Inc. and Sotera Health Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGON
CG Oncology Inc.
$64.03HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT
SHC
Sotera Health Company
$18.38HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT
Total return — CGON vs SHC
growth of $100 · dividends reinvested · last 3yCGON +84.9% (+22.7%/yr)SHC +26.8% (+8.2%/yr)CGON compounded faster over this window
CGON SHC
CGON vs SHC: by the numbers
- •CGON is the larger company ($5.65B vs $5.24B market cap).
- •SHC is profitable (13.44% net margin) while CGON runs a net loss (-3602.68%).
Metrics side by side
Valuation
| Metric | CGON | SHC |
|---|---|---|
| P/E ratio | N/A | 32.11 |
| Forward P/E | N/A | 18.67 |
| P/S ratio | 906.77 | 4.31 |
| P/B ratio | 5.49 | 7.87 |
| EV / EBITDA | N/A | 12.49 |
| FCF yield | N/A | 2.15% |
Profitability
| Metric | CGON | SHC |
|---|---|---|
| Gross margin | -15.02% | 54.72% |
| Operating margin | -4722.13% | 36.24% |
| Net margin | -3602.68% | 13.44% |
| ROE | -21.80% | 24.56% |
| ROIC | -24.33% | 8.80% |
Growth (annualized)
| Metric | CGON | SHC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 6.66% |
| FCF CAGR (5Y) | N/A | 17.34% |
| Total return CAGR (5Y) | N/A | -6.39% |
Frequently asked
- Is CGON or SHC more profitable?
- SHC runs the higher net margin — CGON at -3602.68% versus SHC at 13.44%.
Go deeper
Dig into the metrics
Sotera Health P/E ratioCG Oncology ROESotera Health ROECG Oncology operating marginSotera Health operating marginCG Oncology revenue growthSotera Health revenue growthCG Oncology free cash flowSotera Health free cash flow
CG Oncology & Sotera Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.